Proteome Sciences, Vermillion, Applera, Applied Biosysems, Celerea, NextGen, Expression Pathology, Aushon, Proteros, Merchachem, Hybrigenics, Dualsystems | GenomeWeb
2007 Revs Up Sharply for Proteome Sciences
Proteome Sciences said last week that revenues rose nearly three-fold to £265,593 [$528,601] in 2007, compared to £68,469 in 2006 while losses shrank to £5.25 million last year from £5.64 million in 2006.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.